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b1 integrin–extracellular matrix interactions are
essential for maintaining exocrine pancreas
architecture and function
Matthew M Riopel1,2, Jinming Li1,3, Shangxi Liu3, Andrew Leask3 and Rennian Wang1,3,4

Integrin receptors are responsible for integrating extracellular matrix signals inside the cell. The most prominent integrin
receptor, b1 integrin, has a role in cell function, survival and differentiation. Recently, we demonstrated a profound in vivo
role of b1 integrin expression in the pancreas on glucose homeostasis and islet function. Here, we extend these results by
examining the role of b1 integrin in exocrine pancreatic structure and function. Adult C57Bl/6 mice hemizygous for a
collagen type Ia2 (Col1a2) promoter-controlled tamoxifen-inducible Cre recombinase gene and homozygous for loxP-b1
integrin were injected with tamoxifen or corn oil to generate mice deleted or not for b1 integrin. Pancreata derived from
these male mice were analyzed by quantitative reverse transcriptase-polymerase chain reaction, western blot and immunofluorescence. Our results showed that b1 integrin-deficient mice displayed a significant decrease in pancreas weight
with a significant reduction of amylase, regenerating islet-derived protein II and carboxypeptidase-A expression (Po0.05–
0.01). Compared with control pancreata, b1 integrin-deficient pancreata showed reduced mRNA expression of extracellular matrix (collagen type Ia2, fibronectin and laminin) genes (Po0.05), detached acini clusters and lost focal adhesion
structure. Moreover, b1 integrin-deficient pancreatic acinar cells displayed decreased proliferation (Po0.05) and increased
apoptosis (Po0.001). Apoptosis was reduced to that of controls when isolated exocrine clusters were cultured in media
supplemented with extracellular matrix proteins. Taken together, these results implicate b1 integrin as an essential
component for maintaining exocrine pancreatic structure and function.
Laboratory Investigation (2013) 93, 31–40; doi:10.1038/labinvest.2012.147; published online 15 October 2012
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Integrin receptors have a significant role in cell–cell and cell–
extracellular matrix (ECM) contacts in many different tissue
types. There are 18 a and 8 b receptors capable of forming 24
heterodimeric interactions; yet, half these interactions are
made up by b1 integrin receptors.1 This b1 integrin receptor
group is largely responsible for attachment to the ECM.2 Upon
stimulation, b1 integrin has been shown to mediate cell
motility, survival, proliferation and differentiation.2–5
Pancreatic acini are enclosed round structures that produce
digestive enzymes.6 Basal lamina covers the acini at the basal
surface, stimulating acini integrin receptors.6 Pancreatic
stellate cells (PSCs) are identified as periacinar fibroblast-like
cells of the pancreas that express glial fibrillary acidic protein
(GFAP) and produce ECM proteins in support of surrounding
tissue.7 PSCs are also, in part, responsible for the fibrosis

observed in chronic pancreatitis.8,9 Previous studies have
shown that a3b1 integrin is essential for proper apical/
basolateral cell surface receptor organization and basement
membrane formation in the submandibular gland.10 As well,
b1 integrin deficiency has shown to interfere with laminin-1
expression and basement membrane synthesis and assembly in
embryoid bodies11 and teratoma,12 as well as collagen IV
expression in the lens fiber of mice.13 This is also true for
proper fibronectin assembly, which requires a5b1 integrin.14
b1 integrin has been studied in many tissues, yet the role
of b1 integrin in the postnatal exocrine pancreas is almost
wholly unknown. One recent study examined the effect of
loss of b1 integrin expression in acinar cells during
development; B6-week-old b1 integrin-deficient mice were
susceptible to pancreatitis and displayed aberrant acinar cell
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polarity and necrosis.15 More recently, we have begun to probe
the role of b1 integrin expression in the postnatal, developed
pancreas, using a tamoxifen-dependent cre recombinase
expressed under the control of a collagen I-specific
promoter/enhancer. We demonstrated that adult mice
deficient in b1 integrin showed impaired glucose tolerance
with a significant reduction in pancreatic b-cell function,
consistent with the onset of diabetes. Furthermore, these b1
integrin-deficient mice displayed a significant decrease in
pancreatic focal adhesion kinase and extracellular signalregulated kinase 1/2 activation, along with increased caspase-3
cleavage and decreased cyclin D1 expression.16 However, the
effects of b1 integrin deficiency on pancreatic exocrine
morphology and function in conditional b1 integrindeficient mice have still to be determined.
Here, we used mice homozygous for a loxP-b1 integrin
allele and hemizygous for tamoxifen-dependent cre recombinase
expressed under the control of a collagen type I promoter to
analyze pancreatic exocrine morphology and function
in vivo.16 We found that mice with b1 integrin deficiency
controlled by the collagen I promoter had a primary defect in
PSCs and islets in the pancreas, which led to a significant
decrease in ECM products in the exocrine compartment.
b1 integrin-deficient mice displayed significantly decreased
food intake with a loss of body weight, which was associated
with reduced pancreatic amylase, carboxypeptidase A and
regenerating islet-derived protein II expression. These b1
integrin-deficient mice also demonstrated decreased exocrine
cell proliferation and increased apoptosis. Interestingly,
cultured acinar cell clusters isolated from b1 integrindeficient mouse pancreata in the presence of ECM proteins
showed an improved acinar cell apoptosis. This study indicates
that sufficient ECM and b1 integrin interactions are essential
for maintaining exocrine pancreatic integrity and function.
MATERIALS AND METHODS
Conditional b1 Integrin-Deficient Mice
To generate conditional b1 integrin-deficient mice (b1KO)
in collagen I-producing cells, floxed b1 integrin mice
were crossed with C57BL/6 mice containing CRE-ERT
(tamoxifen-inducible cre recombinase) gene downstream of
the collagen type Ia2 (Col1a2) promoter, as described
previously.17 Progeny mice with positive genotype, as
analyzed by polymerase chain reaction (PCR),17 were
induced by intraperitoneal injection of 1 mg tamoxifen
(4-hydroxytamoxifen; Sigma, St Louis, MO, USA) per mouse
per day for 5 days at 3 weeks of age.16 Corn oil-injected Crepositive and tamoxifen-injected Cre-negative mouse groups
were merged as controls (Ctrl) and experiments were carried
out on male mice at 4 and 7 weeks post-injection. Deletion of
b1 integrin was confirmed by quantitative RT-PCR, western
blot and immunofluorescence as described previously.16 A
Rosa26loxP-STOP-lacZ mouse (Jackson Laboratories), which
does not express the b-galactosidase reporter gene unless cre
recombinase is expressed in the nucleus, was crossed with
32

Col1a2-Cre-ERT to identify the cells within the pancreas that
expressed cre under control of the Col1a2 promoter.17 All
protocols were approved by the Animal Use Subcommittee at
the University of Western Ontario in accordance with the
guidelines of the Canadian Council of Animal Care.
Body and Pancreas Weight and Food Intake Studies
The body and pancreas weight of b1 integrin-deficient and
control mice were measured at 4 and 7 weeks post-injection.
At 4 weeks post-injection, mice from both b1 integrin-deficient and control groups were separated individually and had
their food weighed daily at 0900 hours and monitored their
food intake for a week. Data were expressed as average food
intake per mouse per day.
Acinar Cell Culture Experiments
To isolate acinar cell clusters, both b1 integrin-deficient and
control mouse pancreata at 3 weeks post-injection were dissected and digested with collagenase XI (1 mg/ml; Sigma).
Acinar cell clusters were cultured in modified RPMI 1640
media18 with either 1% BSA (Sigma) or 10% FBS (Invitrogen,
Burlington, ON, Canada), reported to be enriched for ECM
proteins,19,20 for 24 h. Cell clusters from four experimental
groups (b1KO-BSA, Ctrl-BSA, b1KO-FBS, and Ctrl-FBS)
were harvested and processed for immunofluorescence with at
least four mouse pancreata per experimental per group used.
RNA Extraction, Real-Time RT-PCR
Total RNA was extracted from pancreata of b1 integrin-deficient and control mice at 1 week post-injection using the
miRNeasy kit (Qiagen, Germantown, MD, USA).16 For each
reverse transcription reaction, 2 mg of total RNA from whole
pancreatic tissue were used with oligo(dT) and random
primers, as well as Superscript reverse transcriptase
(Invitrogen). Sequences of PCR primers used for RT-PCR
with expected size of product are listed in Table 1. Real-time
RT-PCR analyses were performed as described previously.16
Data were normalized to levels of 18S rRNA subunit and
relative gene expression was calculated based on the 2DDCT
method as PCR signals from b1 integrin-deficient pancreata
relative to control pancreata.16
Protein Extraction and Western Blot Analysis
b1 integrin-deficient and control pancreata, as well as acinar
cell clusters, were sonicated in Nonidet-P40 lysis buffer to
extract protein. Equal amounts (2 mg) of lysate pancreatic
proteins from each experimental group were separated by 10
or 12% sodium dodecyl sulfate-polyacrylamide gel electrophesis and transferred to a nitrocellulose membrane (Bio-Rad
Laboratories, Hercules, CA, USA). Membranes were incubated
with appropriate diluted primary antibodies as listed: mouse
anti-amylase (Santa Cruz Biotechnology, Santa Cruz, CA,
USA); mouse anti-carboxypeptidase A (AbD serotec; Raleigh,
NC, USA); mouse anti-regenerating islet-derived protein II
and goat anti-b1 integrin (R&D System, Minneapolis, MN,
Laboratory Investigation | Volume 93 January 2013 | www.laboratoryinvestigation.org
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Table 1 Sequences of primers used in real-time PCR
Primer

Accession

Primer pair sequence 50 -30

Fragment

name

number

(sense/antisense)

size (bp)

Amy1

NM_007446.2

CAAGTGGAGGTATCGAGAAC

149

CCCTGCTACGCCAATGTCAA
Col1a1

NM_007742.3

Col1a2

NM_007743.2

CCTCCCAGTGGCGGTTATGAC

383

GGGTTCGGGCTGATGTACCAG
AGGGTGAAACTGGTCTCCGA

374

CCCTCCATCACCACGACTTC
Fn1

NM_010233.1

AACTACGATGCCGATCAGAA

263

CCCTCCTCGTGACGCTTGTG
Lama1

NM_008480.2

GGCGGTATAACAACGGAACC

180

GCAATCCACCCACGTAAATC
Lamb1

NM_010721.2

Lamc1

NM_010683.2

CGAGAGTATGAGGCGGCACT

285

CACTTCCACCAAGCGGGTCT
TAGCCAAATTAGCCGACTGC

122

GCTCCCTGGAGGCGATCTCA
18S

NR_003278.1

GTAACCCGTTGAACCCCATTC

151

CCATCCAATCGGTAGTAGCG

USA). Proteins were detected using ECLt-Plus Western blot
detection reagents (Perkin-Elmer, Wellesley, MA, USA) and
exposed using the Versadoc Imaging System (Bio-Rad
Laboratories). Densitometric quantification of bands at
subsaturation levels was performed using the Quantity One
software (Bio-Rad Laboratories) and normalized to appropriate loading controls. Data are expressed as relative expression level of protein to the loading control.16
Serum Assays for Amylase and Pancreatic Lipase
Serum was collected from 7 weeks post-injected b1 integrindeficient and control mice. To measure serum amylase levels,
a Phadebas Test tablet (Magle Life Sciences, Lund, Sweden)
was added to diluted serum samples, based on the manufacturer’s instructions. Amylase activity was measured with a
spectrophotometer and determined by comparing absorbance values to a standard curve.21 To examine the serum
level of pancreatic lipase, serum samples were mixed with
lipase enzyme substrate and enzyme activator as per the
manufacturer’s instructions. Pancreatic lipase activity was
measured using a spectrophotometer and a formula offered
by Genzyme Diagnostics (Charlottetown, PEI, Canada).22
Extracellular Matrix Protein Analysis
Pancreata from b1 integrin-deficient and control mice at 7
weeks post-injection were dissected and fixed in 4% paraformaldehyde. In all, 4-mm-thick pancreatic tissue sections
were prepared from the entire length of the pancreas and
stained with hematoxylin and eosin, Masson’s trichrome (for
total collagen analysis) and picrosirius red (for birefringent
www.laboratoryinvestigation.org | Laboratory Investigation | Volume 93 January 2013

collagen I staining), as described previously.16 To evaluate
quantitatively fibronectin concentration in the pancreas of b1
integrin-deficient and control mice, a fibronectin mouse
sandwich ELISA kit was used (Abcam, Cambridge, MA, USA).
Immunofluorescence and TUNEL Assay
Sets of pancreatic tissue sections (4 mm thick) were immunofluorescently stained with appropriate diluted primary
antibodies as listed: rabbit anti-b1 integrin (Millipore,
Temecula, CA, USA); rabbit anti-Escherichia coli b-galactosidase (Abcam, Cambridge, MA, USA); mouse anti-GFAP
(Pharmingen, Mississauga, ON, Canada); guinea-pig antiinsulin (Zymed, San Francisco, CA, USA) and mouse antilaminin (Developmental Studies Hybridoma Bank, Iowa
City, IA, USA). Fluorescent secondary antibodies were
obtained from Jackson Immunoresearch Laboratories (West
Grove, PA, USA) and 40 -6-diamidino-2-phenylindole (Sigma) was used for nuclear counterstaining.16
To assess the structural organization of focal adhesion
contacts in pancreatic acinar cells, an Actin Cytoskeleton and
Focal Adhesion Staining kit (Chemicon, Temecula, CA, USA)
containing mouse anti-vinculin monoclonal antibody and
TRITC-conjugated phalloidin was used. Cell proliferation
was examined using Ki67 labeling (Abcam).
To examine the cells undergoing apoptosis, the terminal
deoxynucleotidyl transferase-mediated nick-end labeling
(TUNEL) assay was performed.23 Briefly, pancreatic sections
were pretreated with 0.1% trypsin, and then incubated with
the TUNEL reaction mixture conjugated with fluoresceindUTP (Roche, Montreal, QC, Canada). Percent cell
proliferation and apoptosis were calculated by counting
Ki67- or TUNEL-labeled cells in exocrine tissue from at least
12 randomly selected fields of view per pancreatic section.16
Statistical Analysis
Data are expressed as means±s.e.m. Statistical significance was
determined using the unpaired Student’s t-test. Differences
were considered to be statistically significant when Po0.05.
RESULTS
Loss of b1 Integrin Observed in PSCs and Islets with a
Significant Reduction in ECM Expression in the Pancreas
of b1 Integrin-Deficient Mice
To determine the pancreatic cell types that would be directly
affected by the knockout of b1 integrin, transgenic Rosa26loxPSTOP-lacZ mice were crossed with Col1a2-CRE(ER)T mice.17
The resultant mice were injected with tamoxifen to allow
expression of b-galactosidase in cells specifically expressing cre
recombinase under control of the Col1a2 promoter. Cells
within the pancreas positive for b-galactosidase were detected
with an anti-b-galactosidase antibody (Figure 1a). Double
labeling using an antibody directed against GFAP, a marker of
PSCs,24 revealed that the Col1a2 promoter was active in PSCs
(Figure 1a). Moreover, b-galactosidase expression was also
found in islets of the pancreas (Figure 1a). These results
33
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indicate that these two cell populations express cre
recombinase under the control of the Col1a2 promoter.
To examine the effects of b1 integrin loss in PSCs and islets
on pancreas function, mice hemizygous for Col1a2CRE(ER)T and homozygous for loxP-b1 integrin were generated. The resultant mice were injected with either tamoxifen or corn oil to generate mice deleted or not for b1
integrin in PSCs and islets. To assess whether b1 integrindeficient mice pancreas showed altered ECM expression,
quantitative RT-PCR analysis of collagen type Ia1 (Col1a1),
Col1a2, fibronectin 1 (Fn1), laminin a1 (Lama1), laminin b1
(Lamb1) and laminin g1 (Lamc1) mRNA was performed at
1 week post-injection. We found a significant decrease in the
expression of Col1a2 (Po0.001), Fn1 (Po0.05) and Lamc1
(Po0.05) mRNA in b1 integrin-deficient mice pancreata
when compared with controls (Figure 1b–g). These results
indicate that b1 integrin expression on PSCs and islets is
critical in mediating ECM gene expression in the pancreas.
Disturbed Acinar Cell–Cell Contacts and Focal Contact
Complex Observed in the b1 Integrin-Deficient Mouse
Pancreas
Loss of b1 integrin in pancreatic PSCs and islets resulted in
decreased ECM expression; therefore, we set to investigate
any alterations in pancreatic morphology. Based on hematoxylin and eosin stain, we found that pancreatic acini
similarly organized between b1 integrin-deficient and control
mice. However, the detachment of acini clusters from one
another was observed along with very basophilic stain in the
periphery of the acinus in b1 integrin-deficient pancreata
(Figure 2a). Masson’s trichrome (Figure 2b, upper panel) and
picrosirius red (Figure 2b, lower panel) staining revealed a
reduction in collagen fibers and connective tissue between the
acini clusters. Furthermore, analysis of pancreatic fibronectin
protein levels in b1 integrin-deficient mice showed a significant decrease compared with controls (*Po0.05;
Figure 2c). Actin cytoskeleton and focal adhesion staining
showed more robust cytoskeletal fibers along with more
pronounced and continuous vinculin stain in control, but
not b1 integrin-deficient, mouse pancreas at 7 weeks posttamoxifen injection (Figure 2d). Likewise, there was less
colocalization of F-actin and vinculin, suggesting fewer focal
adhesions in 7 weeks post-tamoxifen-injected b1 integrindeficient mice when compared with controls (Figure 2d).
Finally, anti-laminin immunofluorescence showed a dramatic
loss of laminin in 7 weeks post-tamoxifen-injected b1
integrin-deficient mouse pancreas, whereas controls show
clear laminin at cell–cell contacts (Figure 2e).

Reduced b1 Integrin in Acinar Cells, along with
Significantly Reduced Pancreas Weight and Food Intake
Observed in b1 Integrin-Deficient Mice
Although the b-galactosidase stain showed a direct effect on
PSCs and islets, but not acinar cells in the b1 integrin-deficient mouse pancreas, reduced b1 integrin expression stain in
the acinar cell population was observed in 1 week posttamoxifen-injected b1 integrin-deficient mice when compared with controls, but not at 3 days (Figure 3a and b).
Protein expression analyses confirm these results, indicating a
significant reduction in b1 integrin in b1 integrin-deficient
mice at 7 days, but not 3 days, when compared with controls
(*Po0.05; Figure 3c and d). This suggests that loss of b1
integrin expression in the acinar cells may be secondary to
the loss of ECM proteins. Analysis of body and pancreas
weight in 4 and 7 weeks post-tamoxifen-injected b1 integrindeficient mice showed a significantly reduced ratio of
pancreas to body weight at 7 weeks post-injection when
compared with control mice (*Po0.05; Figure 3e). As well, a
significant decrease in food intake was observed in 4 weeks
post-tamoxifen-injected b1 integrin-deficient mice compared
with controls (***Po0.001; Figure 3f).
Significantly Reduced Amylase Expression Observed in
b1 Integrin-Deficient Mice
To assess the defect of b1 integrin deficiency on exocrine
pancreatic products, the expression of amylase mRNA and
protein, as well as serum amylase levels, was examined. We
found that b1 integrin-deficient mice compared with controls had significant decreases in amylase mRNA expression
(*Po0.05; Figure 4a), with a 50% reduction in serum amylase level (***Po0.01; Figure 4b) and total amylase protein
expression in the pancreas (*Po0.05; Figure 4d). Furthermore, serum pancreatic lipase activity was significantly reduced
in b1 integrin-deficient mice, but not controls (*Po0.05;
Figure 4c). Protein expression level of carboxypeptidase A
and regenerating islet-derived protein II was also significantly
decreased in b1 integrin-deficient pancreata when compared
with controls at 7 weeks post-injection (*Po0.05–
***Po0.01; Figure 4e and f), confirming reduced pancreatic
exocrine cell function in b1 integrin-deficient mice.
Reduced b1 Integrin in Acinar Cells Led to Significantly
Increased Cell Apoptosis, which was Partially Rescued
by Culturing Acinar Cell Clusters with ECM Proteins
To analyze the proliferative and apoptotic status of b1
integrin-deficient mouse pancreas, Ki67 immunofluorescence
staining and TUNEL was conducted. The percent of Ki67-

Figure 1 (a) Representative immunofluorescence images of the pancreas of a transgenic Rosa26loxP-STOP-lacZ mouse crossed with a Col1a2-CRE(ER)T
mouse, whereby the b-galactosidase reporter gene is expressed only if cre recombinase is present using anti-glial fibrillary acidic protein (GFAP), antib-galactosidase and anti-insulin antibodies (arrows indicate colocalization of GFAP and b-galactosidase, while arrowheads show no colocalization). (b)
Relative mRNA expression (normalized to 18S subunit) of collagen type Ia1 (Col1a1), Col1a2, fibronectin 1 (Fn1), laminin a1 (Lama1), laminin b1 (Lamb1)
and laminin g1 (Lamc1) of b1 integrin-deficient and control mouse pancreas at 1 week post-tamoxifen injection (n ¼ 3–5). Data are expressed as
means±s.e.m. *Po0.05, ***Po0.001 vs controls.
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positive proliferating acinar cells was significantly decreased
in b1 integrin-deficient mice at 7 weeks post-tamoxifen injection when compared with control mice (*Po0.05;
Figure 5a). Furthermore, a significant increase in acinar cells
undergoing apoptosis was observed in b1 integrin-deficient
mice (***Po0.001; Figure 5b).
Since the primary b1 integrin defect was in PSCs and islets,
we hypothesized that the pancreatic exocrine dysfunction is
due to problematic ECM stimulation of acini. To investigate
this, we isolated acinar cell clusters from control and b1 integrin-deficient pancreata and cultured them with or without
FBS that contains rich ECM proteins.19,20 b1 integrindeficient acinar cell clusters cultured with BSA showed
significantly increased cell apoptosis when compared with the
control cell clusters (*Po0.05; Figure 5c). However, the
number of TUNEL-positive cells in b1 integrin-deficient
acinar cell clusters was reduced and reached control levels
when cultured with FBS medium (*Po0.05; Figure 5c).
DISCUSSION
This study analyzed the effects of b1 integrin deficiency on
pancreatic exocrine tissue. Our results demonstrate that b1
integrin deficiency under control of the collagen I promoter
directly affected PSCs and islets, and this led to significantly
reduced ECM protein production in the pancreas. PSCs
support parenchyma by secreting ECM components that
integrins use as ligands. Indeed, PSCs in human pancreatic
acini stain positive for collagens I, III and IV, laminin,
fibronectin and other ECM proteins.7 Furthermore, there is a
necessity of a5b1 integrin in connective tissue growth factor
stimulation of PSC collagen I synthesis.25 It has also been
reported that PSC secretion of growth factors and ECM
components are, in part, responsible for fibrosis in chronic
pancreatitis.8,9 Our results support previous research, in that
b1 integrin is required to maintain PSC expression of certain
ECM proteins, including Col1a2, Fn1 and Lamc1.
Our observation of reduced pancreatic ECM mRNA was
concomitant with disrupted cell–cell contacts between acini
along with reduced connective tissue and collagen fibers,
laminin immunoreactivity and acinar cell expression of b1
integrin. It is unclear precisely which process preceded the
other, but studies have demonstrated that b1 integrin loss led
to improper basement membrane assembly and laminin expression in teratoma12 and embryoid bodies,11 implicating b1
integrin as an essential part of ECM maintenance. It has also
been demonstrated that ECM proteins can regulate integrin

expression in human fibroblasts.26 Ablation of b1 integrin by
inactivating monoclonal antibody treatment disrupted cell–
cell contacts of keratinocytes.27 Likewise, mouse mammary
gland alveoli deficient of b1 integrin could not attach to the
basement membrane laminin substratum.28 This study also
showed decreased focal adhesion contacts in b1 integrindeficient mammary epithelium when compared with
controls.27 Taken together, the findings of this study
demonstrate that reduced b1 integrin in PSCs had a direct
effect on ECM expression, which in turn effected acinar cell b1
integrin expression, cell–cell interactions, and subsequently
cell proliferation and death.
b1 integrin has been well-established as upstream of the
mitogen-activated protein kinase pathway, which has profound effects on cell survival and proliferation.16,23 Our
previous analysis of b1 integrin-deficient mice demonstrated
a significant reduction in focal adhesion kinase and
extracellular signal-regulated kinase 1/2 phosphorylation,
indicating reduced mitogen-activated protein kinase
signaling.16 Our results corroborate these studies by
demonstrating a reduction in pancreatic b1 integrin, along
with significantly decreased proliferation and increased
apoptosis. To elucidate if the observed effects of pancreatic
exocrine dysfunction were due to b1 integrin or ECM protein
deficiency, isolated exocrine cell clusters from b1 integrindeficient and control mouse pancreas were cultured in ECMenriched medium. Our data indicate that apoptosis was
significantly reduced in b1 integrin-deficient cell clusters
when cultured in media with FBS, suggesting that
supplementing ECM via FBS to b1 integrin-deficient cell
clusters can improve their survival status. This strengthens
our working model, whereby pancreatic exocrine defects
associated with b1 integrin deficiency may be largely due to
insufficient ECM proteins.
It was noted that food intake was significantly reduced in
b1 integrin-deficient mice at 4 weeks post-tamoxifen injection along with a significant decrease in body weight.16 Many
studies have established a positive correlation between food
consumption and weight gain.29,30 Food intake is controlled
by a brain–gut axis associated with multiple factors including
pancreatic enzyme secretion.31–33 Our data demonstrated a
significant reduction in pancreatic lipase, amylase and
carboxypeptidase A expression, major enzymes produced by
the exocrine pancreas, in b1 integrin-deficient mice when
compared with controls, suggesting that the pancreatic
insufficiency occurred because of a loss of ECM proteins

Figure 2 (a) Hematoxylin and eosin, (b) picrosirius red (upper panels) and trichrome (lower panels) staining of b1 integrin-deficient and control mouse
pancreas at 7 weeks post-injection. Black arrows indicate positive collagen and connective tissue stain in controls with fewer in b1 integrin-deficient
mice. (c) Relative fibronectin concentration between b1 integrin-deficient and control (Ctrl) mice at 4 and 7 weeks post-injection (n ¼ 3–4). Data are
expressed as means±s.e.m. *Po0.05 vs control. Immunofluorescence was used to investigate focal adhesions (d) and laminin expression (e). Focal
contacts are defined by vinculin (green) and actin filaments by tetramethyl rhodamine isothiocyanate (TRITC)-conjugated phalloidin (red). Nuclei are
counterstained by 40 -6-diamidino-2-phenylindole (DAPI) (blue). Boxed regions display zoom, while arrows display cell–cell contacts in focal adhesion
and laminin immunofluorescence in control, but not b1 integrin-deficient mouse pancreas. Scale bar ¼ 100 mm (a) and 50 mm (b, d and e).
KO, knockout.
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Figure 3 Representative immunofluorescence images of b1 integrin-deficient and control mouse pancreas at 3 (a) and 7 days (b) post-tamoxifen
injection using an anti-b1 integrin antibody. Western blot analyses of b1 integrin-deficient and control mouse b1 integrin expression at 3 (c) and 7 days
(d) post-tamoxifen injection (n ¼ 4). (e) Pancreas to body weight ratio in b1 integrin-deficient and control mice at 4 and 7 weeks post-injection
(n ¼ 7–17). (f) Food intake data from 4 weeks post-tamoxifen-injected b1 integrin-deficient mice with respective controls (n ¼ 7–8). Data are expressed
as means±s.e.m. *Po0.05; ***Po0.001 vs controls. Scale bar ¼ 50 mm. Ctrl, control; KO, knockout.
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Figure 4 (a) Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis of amylase mRNA expression in 1 week post-injected
b1 integrin-deficient and control mouse pancreas (n ¼ 3). Analysis of serum (b) and pancreatic protein (d) amylase and serum pancreatic lipase (c) in 7
weeks post-injected b1 integrin-deficient and control mice (n ¼ 3–10). Relative carboxypeptidase-A (CPA) (d) and regenerating islet-derived protein II
(Reg-II) (e) protein expression in the pancreas of 7 weeks post-injected b1 integrin-deficient and control mice pancreas (n ¼ 4). Data are expressed as
means±s.e.m. *Po0.05, **Po0.01 vs controls. Ctrl, control; KO, knockout.

Figure 5 Quantitative analysis of cell proliferation (a) and apoptosis (b) in the exocrine pancreas of b1 integrin-deficient and control mice at 7 weeks
post-injection. (c) Apoptosis in exocrine cell clusters cultured in either bovine serum albumin (BSA) or fetal bovine serum (FBS) for 24 h. The percentage
of Ki67- or terminal deoxynucleotidyl transferase mediated nick-end labeling (TUNEL)-positive cells over total number of cells counted was calculated
and data are expressed as means±s.e.m. (n ¼ 4). *Po0.05, ***Po0.001 vs controls. Ctrl, control; KO, knockout.

www.laboratoryinvestigation.org | Laboratory Investigation | Volume 93 January 2013

39

b1 integrin loss impairs the pancreas
MM Riopel et al

and b1 integrin in the pancreas. The pancreas of b1 integrindeficient mice became significantly underweight at 7 weeks
post-tamoxifen injection,16 which was more drastic than the
drop in body weight as shown by the ratio of pancreas to
body weight. This ratio was significantly decreased in b1
integrin-deficient mice when compared with controls, further
indicating a severe pancreatic defect. Meanwhile, other
research has shown that reduction in food intake decreases
serum32 and pancreatic33 amylase, which may be related to
lower insulin levels. These studies are in line with our
research, whereby b1 integrin-deficient mice display reduced
pancreatic insulin along with reduced serum amylase activity
and pancreatic amylase protein and mRNA expression.16
Therefore, the lack of pancreatic ECM proteins or b1 integrin
affected pancreatic enzyme levels, which may have negatively
affected food intake, and thus body weight.
In summary, b1 integrin-deficient mice showed significant
pancreatic exocrine dysfunction compared with controls. The
decrease in pancreas to body weight ratio, essential pancreatic
digestive enzymes and ECM matrix expression all suggest
that b1 integrin and ECM proteins have an important role in
maintaining pancreatic function and differentiation. Furthermore, we observed increased cell death and reduced cell
proliferation, indicating disturbed cell survival/apoptosis
homeostasis. A recovery in apoptosis was observed after b1
integrin-deficient cell clusters were provided ECM proteins.
Taken together, these results implicate b1 integrin as an essential component to maintain ECM expression along with
exocrine pancreatic structure and function.
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